[L-dopa with extracerebral dope-decarboxylase inhibitor (MK-486) in the treatment of Parkinson's disease. Preliminary evaluation of results].
D000328:Adult; D000368:Aged; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002230:Carbidopa / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004338:Drug Combinations; D007980:Levodopa; D002230:Carbidopa
L-dopa z inhibitorem pozamózgowej dopadekarboksylazy (MK-486) w leczeniu choroby Parkinsona -- ocena wyników wstepnych